About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Hypertension Clinical Trials in Philadelphia | 380 Studies

Clinical Trials HypertensionPhiladelphia

Hypertension Clinical Trials in Philadelphia

Find 380 clinical trials for hypertension near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Hypertension trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 361-380 of 380 trials

CompletedBLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEFHeart failure with preserved ejection fraction (HFpEF) is a critical public health problem.NCT04434664·Philadelphia, Pennsylvania CompletedComparing the Effect of the Water Drinking Test on Intraocular PressureA test that was common in the 1960's and was used to detect primary open angle glaucoma was the water drinking test (patients drank 1 quart of water to stress the fluid drainage…NCT02001155·Philadelphia, Pennsylvania CompletedSocial Forces to Improve Statin Adherence (Study A)To assess the effectiveness of reporting statin adherence patterns to a Medication Adherence Partner (MAP) in improving the outcome of statin adherence versus usual care as…NCT02018809·Philadelphia, Pennsylvania

Hypertension Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedWater Drinking Test in Patients With Occludable AngleThe water drinking test (WDT), is a predictive test that has been used to detect primary open angle glaucoma and recently has been demonstrated as a predictor of the diurnal…NCT02613533·Philadelphia, Pennsylvania

CompletedA 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG)The primary objectives of this study are to compare the safety, tolerability, and mean change from baseline in diurnal intraocular pressure (IOP) of ONO-9054 30 µg/mL (0.003%) to…NCT02083289·Los Angeles, California and 11 others

TerminatedEarly, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)A two-stage prospective observational cohort study in scleroderma patients to evaluate screening tests and the incidence of pulmonary arterial hypertension and pulmonary…NCT00706082·Birmingham, Alabama and 82 others

CompletedWay to Health, Healthy MeasuresThe primary objective of the study is to assess the effect of financial incentives on the use of home health monitoring devices among high-risk patients.NCT01282957·Philadelphia, Pennsylvania

CompletedRheos® Pivotal TrialThe purpose of this clinical trial is to demonstrate the efficacy and safety of the Rheos system in subjects with hypertension that are resistant to treatment with at least three…NCT00442286·Birmingham, Alabama and 43 others

Not yet recruitingTiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)The primary objective of this study is to compare the efficacy, safety, and tolerability of tiprelestat plus Standard of Care (SOC) compared with placebo plus SOC in patients with…NCT07601295·Tucson, Arizona and 9 others

CompletedA 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With GlaucomaTo demonstrate statistical superiority of the combination of latanoprost and timolol to the individual therapy of latanoprost and timolol based on intraocular pressure…NCT00277498·Birmingham, Alabama and 63 others

CompletedLifestyle Modification and Blood Pressure StudyThe purpose of this study is to compare the effects of 24 weeks of either a blood pressure education and walking program versus a yoga exercise program versus the combined…NCT00964847·Philadelphia, Pennsylvania

CompletedAtacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of AgeStudy 261A is a dose-ranging and safety study of candesartan cilexetil.NCT00244634·Beverly Hills, California and 43 others

CompletedBrain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)Traumatic brain injury (TBI) is a major cause of death and disability, with an estimated cost of 45 billion dollars a year in the United States alone.NCT00974259·Miami, Florida and 9 others

CompletedEffects of Head Elevation on Intracranial Pressure in ChildrenHead injury is the most common cause of mortality and acquired disability in childhood.NCT00636376·Philadelphia, Pennsylvania

RecruitingA Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)This study evaluates the effect of ROC-101 in adults with either Pulmonary Arterial Hypertension (PAH) or Pulmonary Hypertension Associated with Interstitial Lung Disease (ILD-PH).NCT07175038·Phoenix, Arizona and 22 others

Completed11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary HypertensionThis study is looking at differences in metabolism and functional imaging between pulmonary hypertension subjects with normal right ventricular function and persistent right…NCT01917136·Philadelphia, Pennsylvania

TerminatedCXA-10 Study in Subjects With Pulmonary Arterial HypertensionThis is a Phase 2, multicenter, open-label extension (OLE) of study CXA-10-301, to evaluate the long term safety and efficacy of daily dosing of CXA-10.NCT04053543·Birmingham, Alabama and 36 others

CompletedA Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor BlockerThe purpose of this study is to learn whether dapagliflozin, after 12 weeks, can improve (decrease) blood pressure in patients with type 2 diabetes with uncontrolled hypertension…NCT01137474·Birmingham, Alabama and 328 others

TerminatedPhosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart FailureThis study is a multi-center, prospective, randomized, double blind, placebo-controlled clinical trial.NCT01910389·Huntsville, Alabama and 62 others

CompletedComparison of 2 Beta Blocker Drugs on Peripheral Arterial Disease in Patients With High Blood PressureThis is a 26-week, prospective double-blind, randomized pilot trial of nebivolol versus an active control, metoprolol succinate, in patients with established lower-extremity…NCT01499134·Philadelphia, Pennsylvania

PreviousPage 19 of 19

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia